The Role of Erzhi Tiangui Formula in Expected POR Women Undergoing IVF-ET
Status:
Not yet recruiting
Trial end date:
2025-12-31
Target enrollment:
Participant gender:
Summary
This randomized controlled trial aims to determine whether Erzhi Tiangui Formula can optimize
the reproductive outcomes of elderly patients with expected poor ovarian response, and to
provide a new approach to traditional Chinese medicine assisted in vitro fertilization and
embryo transfer (IVF-ET).
Phase:
Phase 3
Details
Lead Sponsor:
Shandong University of Traditional Chinese Medicine
Collaborators:
Chongqing Medical Center for Women and Children First Affiliated Hospital of Wenzhou Medical University Hospital for Reproductive Medicine Affiliated to Shandong University Maternal and Child Health Care Hospital of Shandong Province Maternity and Child Health Care of Zaozhuang Shanxi Provincial Maternity and Children's Hospital The 960th Hospital of the PLA Joint Logistics Support Force The Second Hospital of Hebei Medical University Yantai Shan Hospital